MedPath

Effect of Silimarina (Livergo) on liver enzymes in patients taking Isotretinoi

Not Applicable
Conditions
????.
Acne vulgaris
Registration Number
IRCT2016080814229N5
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Inclusion criteria included: Acne; treatment with isotretinoin; aged between 15 -50 and Consent to participate in research. Exclusion criteria included:
Liver disease; history of alcohol use; pregnancy and sensitivity to Livergo.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alanine Transaminase. Timepoint: Before and after 30 days. Method of measurement: U/L - Laboratory kit.;Aspartate transaminase. Timepoint: Before and after 30 days. Method of measurement: U/L - Laboratory kit.;Alkaline Phosphatase. Timepoint: Before and after 30 days. Method of measurement: U/L - Laboratory kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath